Use of a Novel 3D Culture Model to Elucidate the Role of Mesothelial Cells, Fibroblasts and Extra-cellular Matrices on Adhesion and Invasion of Ovarian Cancer Cells to the Omentum

Cited by (243)

Items 101–200 of 243

1. Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer
   Carla S. Milagre, Ganga Gopinathan, Gemma L.A. Everitt, Richard G. Thompson, Hagen Kulbe, Haihong Zhong, Robert E. Hollingsworth, Richard Philip Grose, David D.L. Bowtell, Daniel Hochhauser et al. · 2015 · Cancer Research
2. Malignant ascites determine the transmesothelial invasion of ovarian cancer cells
   Justyna Mikuła‐Pietrasik, Paweł Uruski, Sebastian Szubert, Dariusz Szpurek, Stefan Sajdak, Andrzej Tykarski, Krzysztof Książek · 2017 · The International Journal of Biochemistry & Cell Biology
3. Mesothelial Cell HIF1α Expression Is Metabolically Downregulated by Metformin to Prevent Oncogenic Tumor-Stromal Crosstalk
   Peter C. Hart, Hilary A. Kenny, Niklas Graßl, Karen M. Watters, Lacey M. Litchfield, Fabian Coscia, Ivana Blaženović, Lisa Ploetzky, Oliver Fiehn, Matthias Mann et al. · 2019 · Cell Reports
4. Squeezing the eggs to grow: The mechanobiology of mammalian folliculogenesis
   Arikta Biswas, Boon Heng Ng, Vinod S O Prabhakaran, Chii Jou Chan · 2022 · Frontiers in Cell and Developmental Biology
5. Selective Inhibition of Prostaglandin E2 Receptors EP2 and EP4 Inhibits Adhesion of Human Endometriotic Epithelial and Stromal Cells Through Suppression of Integrin-Mediated Mechanisms1
   JeHoon Lee, Sakhila K. Banu, Robert C. Burghardt, Anna Starzinski‐Powitz, Joe A. Arosh · 2012 · Biology of Reproduction
6. Beyond mouse cancer models: Three-dimensional human-relevant in vitro and non-mammalian in vivo models for photodynamic therapy
   Małgorzata Kucińska, Marek Murias, Patrycja M. Nowak-Sliwinska · 2016 · Mutation Research/Reviews in Mutation Research
7. Mesothelial cells are not a source of adipocytes in mice
   Gregory P. Westcott, Margo P. Emont, Jin Li, Christopher L. Jacobs, Linus T.-Y. Tsai, Evan D. Rosen · 2021 · Cell Reports
8. Application of Ovarian Cancer Organoids in Precision Medicine: Key Challenges and Current Opportunities
   Jiani Yang, Shan Huang, Shanshan Cheng, Yue Jin, Nan Zhang, Yu Wang · 2021 · Frontiers in Cell and Developmental Biology
9. Elevation of seprase expression and promotion of an invasive phenotype by collagenous matrices in ovarian tumor cells
   Alanna Kennedy, Huan Dong, Donghai Chen, Wen‐Tien Chen · 2008 · International Journal of Cancer
10. Downregulation of connective tissue growth factor by three‐dimensional matrix enhances ovarian carcinoma cell invasion
    Maria V. Barbolina, Brian P. Adley, David L. Kelly, Jaclyn A. Shepard, Angela J. Fought, Denise M. Scholtens, Peter Penzes, Lonnie D. Shea, Mary Sharon Stack · 2009 · International Journal of Cancer
11. A new 3D organotypic model of ovarian cancer to help evaluate the antimetastatic activity of RAPTA-C conjugated micelles
    Mingxia Lu, Claire Elizabeth Henry, Haiwang Lai, Yee Yee Khine, Caroline Elizabeth Ford, Martina H. Stenzel · 2019 · Biomaterials Science
12. Transcriptional Landscape of 3D vs. 2D Ovarian Cancer Cell Models
    Rachel Kerslake, Birhanu Belay, Suzana Panfilov, Marcia Hall, Ioannis Kyrou, Harpal Singh Randeva, Jari Hyttinen, Emmanouíl Karteris, Cristina Sisu · 2023 · Cancers
13. Urokinase Plasminogen Activator System–Targeted Delivery of Nanobins as a Novel Ovarian Cancer Therapy
    Yilin Zhang, Hilary A. Kenny, Elden P. Swindell, Anirban Kumar Mitra, Patrick L. Hankins, Richard W. Ahn, Katja Gwin, Andrew Paul Mazar, Thomas V. O’Halloran, Ernst R. Lengyel · 2013 · Molecular Cancer Therapeutics
14. Inhibition of fascin in cancer and stromal cells blocks ovarian cancer metastasis
    Sean McGuire, Betül Kara, Peter C. Hart, ANTHONY G. MONTAG, Kristen Wroblewski, Sarah Fazal, Xin‐Yun Huang, Ernst R. Lengyel, Hilary A. Kenny · 2019 · Gynecologic Oncology
15. Ovarian-Cancer-Associated Extracellular Vesicles: Microenvironmental Regulation and Potential Clinical Applications
    Priyakshi Kalita‐de Croft, Shayna Sharma, Nihar Godbole, Gregory Edward Rice, Carlos Salomón · 2021 · Cells
16. Polycaprolactone/Chitosan Composite Nanofiber Membrane as a Preferred Scaffold for the Culture of Mesothelial Cells and the Repair of Damaged Mesothelium
    Hao-Hsi Kao, Chang‐Yi Kuo, Darshan Tagadur Govindaraju, Kuo-Su Chen, Jyh‐Ping Chen · 2022 · International Journal of Molecular Sciences
17. The Use of Porous Scaffold as a Tumor Model
    Mei Zhang, Philip C. Boughton, Barbara R. Rose, Cheok Soon Lee, Angela Hong · 2013 · International Journal of Biomaterials
18. HOXA9 promotes homotypic and heterotypic cell interactions that facilitate ovarian cancer dissemination via its induction of P-cadherin
    Song Yi Ko, Honami Naora · 2014 · Molecular Cancer
19. Peritoneal mesothelium promotes the progression of ovarian cancer cells in vitro and in a mice xenograft model in vivo
    Justyna Mikuła‐Pietrasik, Patrycja Sosińska, Małgorzata Kucińska, Marek Murias, Konstantin Maksin, Agnieszka Malińska, Agnieszka Ziółkowska, HANNA PIOTROWSKA, Aldona Woźniak, Krzysztof Książek · 2014 · Cancer Letters
20. Metastatic Voyage of Ovarian Cancer Cells in Ascites with the Assistance of Various Cellular Components
    Kaname Uno, Shohei Iyoshi, Masato Yoshihara, Kazuhisa Kitami, Kazumasa Mogi, Hiroki Fujimoto, Mai Sugiyama, Yoshihiro Koya, Yoshihiko Yamakita, Akihiro Nawa et al. · 2022 · International Journal of Molecular Sciences
21. EGF-Receptor Regulation of Matrix Metalloproteinases in Epithelial Ovarian Carcinoma
    Laurie G. Hudson, Natalie M. Moss, Mary Sharon Stack · 2009 · Future Oncology
22. Epidermal Growth Factor Receptor-Mediated Membrane Type 1 Matrix Metalloproteinase Endocytosis Regulates the Transition Between Invasive Versus Expansive Growth of Ovarian Carcinoma Cells in Three-Dimensional Collagen
    Natalie M. Moss, Yue-Ying Liu, Jeffrey J. Johnson, P. Debiase, Jonathan C. R. Jones, L. Hudson, H. Munshi, M. Stack · 2009 · Molecular Cancer Research
23. Tumor cell‑fibroblast heterotypic aggregates in�malignant ascites of patients with ovarian cancer
    Qing Han, Bangxing Huang, Zaiju Huang, Jing Cai, Lanqing Gong, Yifan Zhang, Jiahong Jiang, Weihong Dong, Zehua Wang · 2019 · International Journal of Molecular Medicine
24. Mesothelial vitronectin stimulates migration of ovarian cancer cells
    Loraine Heyman, Johanne Leroy‐Dudal, Julien Fernandes, Damien Seyer, Soizic Dutoit, Franck Carreiras · 2010 · Cell Biology International
25. A High-Throughput Screening Model of the Tumor Microenvironment for Ovarian Cancer Cell Growth
    Lal-Nag, Madhu, McGee, Lauren, Guha, Rajarshi, Lengyel, Ernst, Kenny, Hilary A., Ferrer, Marc · 2017 · SLAS Discovery
26. Expression of the miR200 Family of microRNAs in Mesothelial Cells Suppresses the Dissemination of Ovarian Cancer Cells
    Kazuya Sugiyama, Hiroaki Kajiyama, Kiyosumi Shibata, Hong Yuan, Fumitaka Kikkawa, Takeshi Senga · 2014 · Molecular Cancer Therapeutics
27. SPARC Regulates Transforming Growth Factor Beta Induced (TGFBI) Extracellular Matrix Deposition and Paclitaxel Response in Ovarian Cancer Cells
    David A. Tumbarello, Melissa R. Andrews, James D. Brenton · 2016 · PLoS ONE
28. Prostate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristics.
    Shabnam Ziaee, Gina Chia‐Yi Chu, Jen-Ming Huang, Shirly Sieh, Leland W.K. Chung · 2015 · PubMed Central
29. DDR2 Expression in Cancer-Associated Fibroblasts Promotes Ovarian Cancer Tumor Invasion and Metastasis through Periostin-ITGB1
    Favour A. Akinjiyan, Ritu M. Dave, Emily Alpert, Gregory D. Longmore, Katherine Cynthia Fuh · 2022 · Cancers
30. Tumor-associated fibrosis: a unique mechanism promoting ovarian cancer metastasis and peritoneal dissemination
    Hiroki Fujimoto, Masato Yoshihara, Raymond Joseph Rodgers, Shohei Iyoshi, Kazumasa Mogi, Emiri Miyamoto, Sae Hayakawa, Maia Hayashi, Satoshi Nomura, Kazuhisa Kitami et al. · 2024 · Cancer and Metastasis Reviews
31. An image-based assay to quantify changes in proliferation and viability upon drug treatment in 3D microenvironments
    Vasanth Siruvallur Murali, Bo-Jui Chang, Reto Paul Fiolka, Gaudenz M. Danuser, Murat Can Çobanoğlu, Erik S. Welf · 2019 · BMC Cancer
32. Ovarian Cells Have Increased Proliferation in Response to Heparin-Binding Epidermal Growth Factor as Collagen Density Increases
    Kaitlin C. Fogg, Carine M. Renner, Hannah Christian, Alyssa Walker, Leilani Marty‐Santos, Aisha Khan, Will R. Olson, Carl Parent, Andrea O’Shea, Deneen M. Wellik et al. · 2020 · Tissue Engineering Part A
33. Vulnerability to oxidative stress and different patterns of senescence in human peritoneal mesothelial cell strains.
    K. Książek, Justyna Mikuła-Pietrasik, Sharon J. Olijslagers, A. Jörres, T. von Zglinicki, J. Witowski · 2009 · American Journal of Physiology. Regulatory Integrative and Comparative Physiology
34. Quantitative High-Throughput Screening Using an Organotypic Model Identifies Compounds that Inhibit Ovarian Cancer Metastasis
    Hilary A. Kenny, Madhu Lal‐Nag, Min Shen, Betül Kara, Dominik A. Nahotko, Kristen Wroblewski, Sarah Fazal, Siquan Chen, Chun-Yi Chiang, Yen‐Ju Chen et al. · 2019 · Molecular Cancer Therapeutics
35. Increased metastases are associated with inflammation and matrix metalloproteinase-9 activity at incision sites in a murine model of peritoneal dissemination of colorectal cancer
    In Kyu Lee, Michael Nathan VanSaun, Jung Ho Shim, Lynn McCormick Matrisian, David Lee Gorden · 2012 · Journal of Surgical Research
36. Role of mesenchymal cells in the natural history of ovarian cancer: a review
    Cyril Touboul, Fabien Vidal, Jennifer Pasquier, Raphaêl Lis, Arash Rafii · 2014 · Journal of Translational Medicine
37. Evaluation of Matrix Metalloproteinases, Cytokines and Their Potential Role in the Development of Ovarian Cancer
    Mahmood Rasool, Arif Malik, Muhammad Abdul Basit Ashraf, Gulshan Parveen, Shazia Iqbal, Irfan Ali, Mahmood Husain Qazi, Muhammad Asif, Kashif Kamran, Asim Iqbal et al. · 2016 · PLoS ONE
38. The Homeoprotein DLX4 Stimulates NF-κB Activation and CD44-Mediated Tumor–Mesothelial Cell Interactions in Ovarian Cancer
    Dhwani Haria, Bon Q. Trinh, Song Yi Ko, Nicolas Barengo, Jinsong Liu, Honami Naora · 2015 · American Journal Of Pathology
39. Stromal Interactions as Regulators of Tumor Growth and Therapeutic Response: A Potential Target for Photodynamic Therapy?
    Jonathan P. Celli · 2012 · Israel Journal of Chemistry
40. The functional multipotency of transforming growth factor β signaling at the intersection of senescence and cancer
    Justyna Mikuła‐Pietrasik, Szymon Rutecki, Krzysztof Książek · 2022 · Cellular and Molecular Life Sciences
41. Recapitulating Tumorigenesis in vitro: Opportunities and Challenges of 3D Bioprinting
    Gabriela S. Kronemberger, Guilherme A. S. C. Miranda, Renata Spagolla Napoleão Tavares, B. Meira Montenegro, Úrsula de Almeida Kopke, Leandra Santos Baptista · 2021 · Frontiers in Bioengineering and Biotechnology
42. The Natural Product β-Escin Targets Cancer and Stromal Cells of the Tumor Microenvironment to Inhibit Ovarian Cancer Metastasis
    Hilary A. Kenny, Peter C. Hart, Kasjusz Kordylewicz, Madhu A. Lal, Min Shen, Betül Kara, Yen‐Ju Chen, Niklas Graßl, Yousef Alharbi, Bikash Ranjan Pattnaik et al. · 2021 · Cancers
43. Topological defects in the mesothelium suppress ovarian cancer cell clearance
    Jun Zhang, Ning Yang, Pamela K. Kreeger, Jacob Notbohm · 2021 · APL Bioengineering
44. Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix Proteins
    Angela M. Schab, Molly M. Greenwade, Elizabeth C. Stock, Elena Lomonosova, Kevin Cho, Whitney R. Grither, Hollie M Noia, Daniel Wilke, Mary Margaret Mullen, Andrea R. Hagemann et al. · 2023 · Molecular Cancer Research
45. Simvastatin reduces tumor cell adhesion to human peritoneal mesothelial cells by decreased expression of VCAM-1 and β1 integrin
    Britta Janina Wagner · 2011 · International Journal of Oncology
46. Proliferating fibroblasts and HeLa cells co-cultured in vitro reciprocally influence growth patterns, protein expression, chromatin features and cell survival.
    John G. Delinassios, Flora Angeli, George Koumakis, Shant Kumar, Wen-Hui Kang, Gigliola Sica, Fortunata Iacopino, Gina Lama, Sergio A. Lamprecht, Ina Sigal-Batikoff et al. · 2015 · PubMed
47. A systematic CRISPR screen reveals an IL-20/IL20RA-mediated immune crosstalk to prevent the ovarian cancer metastasis
    Jia Li, Xuan Qin, Jie Shi, Xiaoshuang Wang, Tong Li, Mengyao Xu, Xiaosu Chen, Yujia Zhao, Jiahao Han, Yongjun Piao et al. · 2021 · eLife
48. The role of cancer-associated mesothelial cells in the progression and therapy of ovarian cancer
    Aiping Zheng, Yuhao Wei, Yunuo Zhao, Tao Zhang, Xuelei Ma · 2022 · Frontiers in Immunology
49. Combination Therapy of an Inhibitor of Group VIA Phospholipase A2 with Paclitaxel Is Highly Effective in Blocking Ovarian Cancer Development
    Hui Li, Zhenwen Zhao, Caryl J. Antalis, Zhanzhong Zhao, Robert E. Emerson, Gang Wei, Sheng Zhang, Zhong‐Yin Zhang, Yan Xu · 2011 · American Journal Of Pathology
50. A novel mechanism of neovascularization in peritoneal dissemination via cancer-associated mesothelial cells affected by TGF-β derived from ovarian cancer
    Kayo Fujikake, Hiroaki Kajiyama, Masato Yoshihara, Kimihiro Nishino, Nobuhisa Yoshikawa, Fumi Utsumi, Shiro Suzuki, Kaoru Niimi, Jun Sakata, Hiroko Mitsui et al. · 2017 · Oncology Reports
51. The Müllerian HOXA10 gene promotes growth of ovarian surface epithelial cells by stimulating epithelial–stromal interactions
    Song Yi Ko, Ernst R. Lengyel, Honami Naora · 2009 · Molecular and Cellular Endocrinology
52. A simplified culture system to examine soluble factor interactions between mammalian cells
    Molly J. Carroll, Lauren E. Stopfer, Pamela K. Kreeger · 2013 · Chemical Communications
53. In vitro three-dimensional models in cancer research: a review
    Giorgia Imparato, Francesco Urciuolo, Paolo A. Netti · 2015 · International Materials Reviews
54. Exploring the Potential of Drug Response Assays for Precision Medicine in Ovarian Cancer
    Tanya Singh, Adam S. Neal, Neda A. Moatamed, Sanaz Memarzadeh · 2020 · International Journal of Molecular Sciences
55. In Vitro Models of Ovarian Cancer: Bridging the Gap between Pathophysiology and Mechanistic Models
    Elliot Lopez, Sahil Kamboj, Changchong Chen, Zixu Wang, Sabrina Kellouche, Johanne Leroy‐Dudal, Franck Carreiras, Ambroise Lambert, Carole Aimé · 2023 · Biomolecules
56. Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity
    Pamela Peters, Elizabeth M. Schryver, Ernst R. Lengyel, Hilary A. Kenny · 2015 · Journal of Visualized Experiments
57. Senescence-related deterioration of intercellular junctions in the peritoneal mesothelium promotes the transmesothelial invasion of ovarian cancer cells
    Martyna Pakuła, Anna Witucka, Paweł Uruski, Artur Radziemski, Rafał Moszyński, Dariusz Szpurek, Konstantin Maksin, Aldona Woźniak, Stefan Sajdak, Andrzej Tykarski et al. · 2019 · Scientific Reports
58. Matrix Gla Protein drives stemness and tumor initiation in ovarian cancer
    Valentina Nieddu, Valentina Melocchi, Chiara Battistini, Giulia Franciosa, Michela Lupia, C. Stellato, Giovanni Bertalot, Jesper Velgaard Olsen, Nicoletta Colombo, Fabrizio Bianchi et al. · 2023 · Cell Death and Disease
59. Exosomes: Key Factors in Ovarian Cancer Peritoneal Metastasis and Drug Resistance
    Ming Shao, Yunran Gao, Xiling Xu, David W. Chan, Juan Du · 2024 · Biomolecules
60. Prediction and control of number of cells in microdroplets by stochastic modeling
    Elvan Ceyhan, Feng Xu, Umut Atakan Gurkan, Ahmet Emrehan Emre, Emine Sumeyra Turali Emre, Rami El Assal, Ali Acikgenc, Chung‐An Max Wu, Utkan Demirci · 2012 · Lab on a Chip
61. A Systematic Comparative Assessment of the Response of Ovarian Cancer Cells to the Chemotherapeutic Cisplatin in 3D Models of Various Structural and Biochemical Configurations—Does One Model Type Fit All?
    Priyanka Gupta, Aline F. Miller, Adedamola Olayanju, Thumuluru Kavitha Madhuri, Eirini G. Velliou · 2022 · Cancers
62. Modeling Platinum Sensitive and Resistant High-Grade Serous Ovarian Cancer: Development and Applications of Experimental Systems
    Paula Cunnea, Euan A. Stronach · 2014 · Frontiers in Oncology
63. A 3D multi-cellular tissue model of the human omentum to study the formation of ovarian cancer metastasis
    Manuela Estermann, Ricardo Coelho, Francis Jacob, Yen‐Lin Huang, Ching-Yeu Liang, Ana Bela Faia-Torres, Dedy Septiadi, Barbara Drašler, Bedia Begüm Karakoçak, Irini Magdelina Dijkhoff et al. · 2023 · Biomaterials
64. Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional (3D) Model
    Donna Cvetković, Cameron Glenn-Franklin Goertzen, Moshmi M. Bhattacharya · 2014 · Journal of Visualized Experiments
65. Integrated transcriptomic and proteomic analysis identifies protein kinase CK2 as a key signaling node in an inflammatory cytokine network in ovarian cancer cells
    Hagen Kulbe, Francesco Iorio, Probir Chakravarty, Carla S. Milagre, Robert Moore, Richard G. Thompson, Gemma L.A. Everitt, Monica Canosa, Alexander Montoya, Denis Drygin et al. · 2016 · Oncotarget
66. The Role of Stroma in Ovarian Cancer
    Ana Carolinne Da Silva, Millena Prata Jammal, Paula Carolina Arvelos Crispim, Eddie Fernando Cândido Murta, Rosekeila Simões Nomelini · 2019 · Immunological Investigations
67. Novel Ex Vivo Models of Epithelial Ovarian Cancer: The Future of Biomarker and Therapeutic Research
    James A. Clark, Christina Fotopoulou, Paula Cunnea, Jonathan Krell · 2022 · Frontiers in Oncology
68. Tumor microenvironment-induced FOXM1 regulates ovarian cancer stemness
    Chiara Battistini, Hilary A. Kenny, Melissa Zambuto, Valentina Nieddu, Valentina Melocchi, Alessandra Decio, Pietro Lo Riso, Carlo Emanuele Villa, Alessia Gatto, Mariacristina Ghioni et al. · 2024 · Cell Death and Disease
69. An Immunocompetent, Orthotopic Mouse Model of Epithelial Ovarian Cancer Utilizing Tissue Engineered Tumor Cell Sheets
    Ayumi Arauchi, Chieh-Hsiang Yang, Sungpil Cho, Elke A. Jarboe, C. Matthew Peterson, You Han Bae, Teruo Okano, Margit Maria Janat-Amsbury · 2014 · Tissue Engineering Part C Methods
70. Interactions of Human Peritoneal Mesothelial Cells With Serous Ovarian Cancer Cell Spheroids-Evidence for a Mechanical and Paracrine Barrier Function of the Peritoneal Mesothelium
    Sylvia Stadlmann, Hans Georg Feichtinger, Gregor Mikuz, Christian Marth, Alain Gustave Zeimet, Manfred Herold, Cornelius Knabbe, Felix Albert Offner · 2014 · International Journal of Gynecological Cancer
71. Advantages of the avian model for human ovarian cancer
    Ana de Melo Bernardo, Sólveig Þorsteinsdóttir, Christine L. Mummery · 2015 · Molecular and Clinical Oncology
72. Culture Models to Define Key Mediators of Cancer Matrix Remodeling
    Emily Suzanne Fuller, Viive Maarika Howell · 2014 · Frontiers in Oncology
73. Patient-Derived In Vitro Models of Ovarian Cancer: Powerful Tools to Explore the Biology of the Disease and Develop Personalized Treatments
    Chiara Battistini, Ugo Cavallaro · 2023 · Cancers
74. ROR2/Wnt5a Signaling Regulates Directional Cell Migration and Early Tumor Cell Invasion in Ovarian Cancer
    Whitney R. Grither, Breanna Baker, Vasilios Aris Morikis, Ma. Xenia G. Ilagan, Katherine Cynthia Fuh, Gregory D. Longmore · 2024 · Molecular Cancer Research
75. The interaction of β-arrestin1 with talin1 driven by endothelin A receptor as a feature of α5β1 integrin activation in high-grade serous ovarian cancer
    Ilenia Masi, Flavia Ottavi, Danila Del Rio, Valentina Caprara, Cristina Vastarelli, Sara Maria Giannitelli, Giulia Fianco, Pamela Mozetic, Marianna Buttarelli, Gabriella Ferrandina et al. · 2023 · Cell Death and Disease
76. Biologically relevant 3D tumor arrays: treatment response and the importance of stromal partners
    Imran Rizvi, Jonathan P. Celli, Feng Xu, Conor L. Evans, Adnan O. Abu‐Yousif, Alona Muzikansky, Stefan A. Elrington, Brian W. Pogue, Dianne M. Finkelstein, Utkan Demirci et al. · 2011 · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE
77. The protective activity of mesothelial cells against peritoneal growth of gastrointestinal tumors: The role of soluble ICAM-1
    Justyna Mikuła‐Pietrasik, Paweł Uruski, Małgorzata Kucińska, Andrzej Tykarski, Krzysztof Książek · 2017 · The International Journal of Biochemistry & Cell Biology
78. Single‐cell RNA sequencing captures patient‐level heterogeneity and associated molecular phenotypes in breast cancer pleural effusions
    Holly J. Whitfield, Jean Berthelet, Stefano Mangiola, Caroline Bell, Robin L. Anderson, Bhupinder Pal, Belinda Jane Yeo, Anthony T. Papenfuss, Delphine Mérino, Melissa J. Davis · 2023 · Clinical and Translational Medicine
79. Prognostic significance of matrix metalloproteinase-2 in gynecological cancer: a systemic review of the literature and meta-analysis.
    Hongling Peng, Lei Liu, Xia Zhao · 2013 · PubMed
80. The Therapeutic Potential of Targeting the HGF/cMET Axis in Ovarian Cancer
    Kim Moran‐Jones · 2016 · Molecular Diagnosis & Therapy
81. A human ex vivo coculture model to investigate peritoneal metastasis and innovative treatment options
    Dina Mönch, Jana Koch, Annika Maaß, Nicole Janssen, Thomas E. Mürdter, Philipp Renner, Petra Fallier‐Becker, Wiebke Solaß, Matthias Georg Schwab, Marc‐H. Dahlke et al. · 2021 · Pleura and Peritoneum
82. Establishment of the SIS scaffold-based 3D model of human peritoneum for studying the dissemination of ovarian cancer
    Saskia-Laureen Herbert, Andrea Fick, Motaharehsadat Heydarian, Marco Metzger, Achim Wöckel, Thomas Rudel, Vera Kozjak‐Pavlovic, Christine Wulff · 2022 · Journal of Tissue Engineering
83. Cytokine CCL2 secreted by cancer-associated fibroblasts augments temozolomide resistance in glioblastoma through ERK1/2 signaling
    Mingrong Zuo, Shuxin Zhang, Siliang Chen, Yuze He, Junhong Li, Yufan Xiang, Yunbo Yuan, Tengfei Li, Wanchun Yang, Zhihao Wang et al. · 2025 · Oncogene
84. Procancerogenic activity of senescent cells: A case of the peritoneal mesothelium
    Justyna Mikuła‐Pietrasik, Łukasz Stryczyński, Paweł Uruski, Andrzej Tykarski, Krzysztof Książek · 2018 · Ageing Research Reviews
85. 3D Disease Modelling of Hard and Soft Cancer Using PHA-Based Scaffolds
    Akanksha Tomar, Pinar Uysal Onganer, Pooja Basnett, Uttam Pati, Ipsita Roy · 2022 · Cancers
86. The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone
    Sabrina J. Ritch, Abu Shadat Mohammod Noman, Alicia Alejandra Goyeneche, Carlos Marcelo Telleria · 2022 · Cancer Cell International
87. Building on the foundation of daring hypotheses: Using the MKK4 metastasis suppressor to develop models of dormancy and metastatic colonization
    Matthew T. Knopeke, Eric T. Ritschdorff, Robert Clark, Donald J. Vander Griend, Shaheena Khan, Megan N. Thobe, Jason B. Shear, Carrie W Rinker-Schaeffer · 2011 · FEBS Letters
88. Isolation of Normal and Cancer-Associated Fibroblasts
    Katarzyna Zawieracz, Mark A. Eckert · 2021 · Methods in molecular biology
89. Normal saline remodels the omentum and stimulates its receptivity for transcoelomic metastasis
    Hironari Akasaka, WonJae Lee, Song Yi Ko, Ernst R. Lengyel, Honami Naora · 2023 · JCI Insight
90. Nanomechanical Analysis of Living Small Extracellular Vesicles to Identify Gastric Cancer Cell Malignancy Based on a Biomimetic Peritoneum
    Zhixing Ge, Songchen Dai, Haibo Yu, Junhua Zhao, Wenguang Yang, Wenjun Tan, Jingxu Sun, Quan Gan, Lianqing Liu, Zhenning Wang · 2024 · ACS Nano
91. Navitoclax, a Bcl-2/xL Inhibitor, and YM155, a Survivin Inhibitor, in Combination with Carboplatin, Effectively Inhibit Ovarian Cancer Tumor Growth
    Hilary A. Kenny, Carman Ka Man Ip, Lucy Kelliher, Tejas Samantaray, Kasjusz Kordylewicz, Rachael Hoffmann, Sarah Rauch, Beatrice Malacrida, Sophie L.P. Skingsley, Frances R. Balkwill et al. · 2025 · Molecular Cancer Therapeutics
92. Biomimetic construction of peritoneum to imitate peritoneal metastasis using digital micromirror device-based optical projection lithography
    Zhixing Ge, Junhua Zhao, Haibo Yu, Wenguang Yang, Peilin Zhou, Zhenning Wang, Lianqing Liu · 2020 · Lab on a Chip
93. Regulation of Mesothelial Cell Fate during Development and Human Diseases
    Toshiaki Taniguchi, Hiroyuki Tomita, Tomohiro Kanayama, Kazumasa Mogi, Yoshihiro Koya, Yoshihiko Yamakita, Masato Yoshihara, Hiroaki Kajiyama, Akira Hara · 2022 · International Journal of Molecular Sciences
94. Translation and Applications of Biofabrication
    Ji Hyun Kim, Anthony Atala, James J. Yoo · 2016 · Springer eBooks
95. A Perspective Review: Analyzing Collagen Alterations in Ovarian Cancer by High-Resolution Optical Microscopy
    Kristal L. Gant, Manish S. Patankar, Paul J. Campagnola · 2024 · Cancers
96. Adipocyte-derived CXCL10 in obesity promotes the migration and invasion of ovarian cancer cells
    Zhe Wang, Qingjian Ou, Ying Liu, Yuanyuan Liu, Qingwei Zhu, Jing Feng, Fengze Han, Lu Gao · 2024 · Journal of Ovarian Research
97. Thy-1+/−fibroblast subsets in the human peritoneum
    Edyta Kawka, Janusz Witowski, Maria Bartosova, Rusan Ali Catar, A Hatz Rudolf, Aurélie Philippe, Rafał Rutkowski, Betti Schaefer, Claus Peter Schmitt, Duska Dragun et al. · 2017 · American Journal of Physiology-Renal Physiology
98. Models for measuring metabolic chemical changes in the metastasis of high grade serous ovarian cancer: fallopian tube, ovary, and omentum
    Hannah J. Lusk, Joanna E. Burdette, Laura M. Sanchez · 2021 · Molecular Omics
99. Utilization of a 3-D tissue engineered model to investigate the effects of perfusion on gynecologic cancer biology
    Alba Martínez, Molly Buckley, Carly Bess Scalise, Dezhi Wang, Ashwini A. Katre, Michael J. Birrer, Joel L. Berry, Rebecca Christian Arend · 2021 · Journal of Tissue Engineering
100. Patient-derived and artificial ascites have minor effects on MeT-5A mesothelial cells and do not facilitate ovarian cancer cell adhesion
     Manuela Estermann, Yen‐Lin Huang, Dedy Septiadi, Danilo Ritz, Ching-Yeu Liang, Francis Jacob, Barbara Drašler, Alke Petri‐Fink, Viola A Heinzelmann-Schwarz, Barbara Rothen‐Rutishauser · 2020 · PLoS ONE